Innotox is the world’s first liquid injectable form of botulinum Toxin type A approved by KFDA in South Korea, 2013. Allergan, the Botox manufacturer, made an exclusive license agreement to market Innotox worldwide, excluding Korea and Japan. Made by Medytox in Korea.

Innotox 100U is a South Korean innovative product for smoothing mimic wrinkles on the face. Unlike well-known Botox, it has a liquid pharmaceutical form and an improved formula. It is popular in many countries thanks to the ease of use and long-lasting result.